Pfizer’s Grange Castle plant in Dublin will be upgraded to produce the Covid-19 vaccine developed by the US-headquartered pharmaceutical giant and its German partner BioNTech. Pfizer confirmed the development this Wednesday, following its exclusive reporting by The Currency on Tuesday. The company said up to approximately $40 million will be invested in Grange Castle and an additional 75 roles will be recruited as part of an expansion of its European-based facilities to be part of the worldwide Covid-19 vaccine supply chain. “Pfizer’s Grange Castle facility will produce mRNA drug substance. Given the extensive technical transfer process, on-site development, equipment installation…

Want to continue reading?

Join today with an Annual membership and get full access to The Currency for just €200 (68c per day) or try monthly membership for just €5 for your first month.

Subscribe

Cancel at any time.

Are you already a member? .